[1]
“Hypodermoclysis in patients under palliative care: new pharmaceutical recommendations for clinical practice”, RBM, vol. 28, no. 2, p. e-20252099, Jan. 2025, doi: 10.25061/2527-2675/ReBraM/2025.v28i2.2099.